AVG.F Avantor Inc.
- Market cap
- EUR 9.38B
- P/E
- 32.2x
- P/B
- 1.78x
- ROE
- 6.5%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is AVG.F undervalued?
Graham numberAVG.F trades 59.6% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Avantor Inc. fundamental analysis
No fundamental analysis for Avantor Inc. yet.
Avantor Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Avantor Inc.
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chrom…
Full company profileAvantor Inc. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Avantor Inc. annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 7.51B | 6.97B | 6.78B | 6.55B | 6.63B |
| Gross Profit | 2.60B | 2.36B | 2.28B | 2.14B | 2.10B |
| Operating Income | 1.13B | 857M | 638M | 544M | 481M |
| EBITDA | 1.52B | 1.10B | 1.48B | 139M | 897M |
| Net Income | 687M | 321M | 712M | -530M | 380M |
| EPS | 1.02 | 0.47 | 1.05 | -0.78 | 0.56 |
| Balance Sheet | |||||
| Total Assets | 13.5B | 13.0B | 12.1B | 11.8B | 11.6B |
| Total Liabilities | 8.61B | 7.72B | 6.16B | 6.23B | 5.79B |
| Shareholders' Equity | 4.86B | 5.25B | 5.96B | 5.57B | 5.84B |
| Cash & Short-term Investments | 373M | 263M | 262M | 365M | 464M |
| Cash Flow | |||||
| Operating Cash Flow | 844M | 870M | 841M | 624M | 576M |
| Capital Expenditure | 133M | 146M | 149M | 129M | 147M |
| Free Cash Flow | 710M | 724M | 692M | 495M | 429M |
| Ratios | |||||
| ROE | 14.1% | 6.1% | 11.9% | -9.5% | 6.5% |
| ROA | 5.1% | 2.5% | 5.9% | -4.5% | 3.3% |
| Net Profit Margin | 9.1% | 4.6% | 10.5% | -8.1% | 5.7% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Avantor Inc. dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | USD 32.4M | 0.05 | 4.7% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Avantor Inc.
- Insiders 1.54%
- Institutions 98.47%
- Public & others 0.00%
- Shares outstanding 678M
- Free float 659M
Avantor Inc. company profile
- Company name
- Avantor Inc.
- Ticker
- AVG.F
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Employees
- 13,500
- Fiscal year end
- December
- Address
- Radnor Corporate Center, Radnor, PA, United States, 19087
- Phone
- 610 386 1700
- Website
- avantorsciences.com
About Avantor Inc.
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Avantor Inc. management
10- Mr. Emmanuel LignerPresident, CEO & Director · born 1971
- Mr. Claudius O. SokenuExecutive VP, Corporate Secretary and Chief Legal & Compliance Officer · born 1968
- Mr. Corey D. WalkerPresident of Laboratory Solutions · born 1978
- Mr. Benoit GourdierExecutive Vice President of Bioscience Production · born 1967
- Ms. Mary BlennExecutive VP & COO
- Mr. Steven W. EckSenior VP, Corporate Controller & Chief Accounting Officer · born 1976
- Mr. Mikey SantiagoChief Information Officer
- Mr. Chris FidykVice President of Investor Relations
- Ms. Brittany HankamerExecutive VP & Chief Human Resources Officer · born 1971
- Mr. Christophe Couturier M.B.AExecutive Vice President of AMEA · born 1966